Oromucosal delta9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: an uncontrolled, open-label, 2-year extension trial.

Subject: Multiple Sclerosis - PUBLISHED VIA Clinical Therapeutics

Rog DJ, Nurmikko TJ, Young CA

Walton Centre for Neurology and Neurosurgery, Liverpool, United Kingdom. djrdjr@doctors.org.uk

View Source >> (Price: $36)

Related Studies:

View all medical studies

Learn More About Cannabis